Literature DB >> 7070601

The role of the caudate-putamen nucleus in salivary secretion induced by L-DOPA.

J H Pazo, J H Medina, O R Tumilasci.   

Abstract

Experiments were performed in rats of the Wistar strain anesthetized with alpha-chloralose (100 mg/kg). Electrolytic lesion of either components of the striopallidal complex (corpus striatum, globus pallidus or entopeduncular nucleus) reduced the sensory response to L-DOPA in the contralateral submaxillary glands. Damage to other neural structures, directly or indirectly related to the striopallidal system, left the salivary response unaffected. These structures were: substantia nigra, cerebral cortex, ventromedial and center median-parafascicular thalamic nuclei, nucleus accumbens and posterior hypothalamic areas, including the medial forebrain bundle and lateral habenular nucleus. However, lesions placed in H1-H2 fields of Forel and reticular formation, lateral to the periaqueductal gray, reduced the salivary response in the contralateral glands. This effect was similar to that observed in animals with lesions of the striopallidal complex. From this study, it is concluded that the striatum is the target area for the central effect of L-DOPA on salivary secretion, by activation of pathways descending through the fields of Forel and mesencephalic reticular formation to the contralateral lower brain stem.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7070601     DOI: 10.1016/0028-3908(82)90196-4

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  2 in total

1.  Frequency and factors related to drooling in Chinese patients with multiple system atrophy: a cross-sectional study.

Authors:  Yalan Chen; Hongyan Huang; Pingping Ning; Quanzhen Zhao; Hui Wang; Qiuyan Shen; Yanming Xu
Journal:  Clin Auton Res       Date:  2019-03-12       Impact factor: 4.435

Review 2.  Sialorrhoea and drooling in patients with Parkinson's disease: epidemiology and management.

Authors:  Marcelo Merello
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.